![Sarah Bhagat](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sarah Bhagat
Directeur/Membre du Conseil chez
Aeovian Pharmaceuticals, Inc.
Profil
Sarah Bhagat currently works at Aeovian Pharmaceuticals, Inc., as Board Member from 2019.
Dr. Bhagat also formerly worked at Inozyme Pharma, Inc., as Independent Director from 2019 to 2025, Sofinnova Investments, Inc., as General Partner from 2020 to 2022, and Atsena Therapeutics, Inc., as Chairperson.
Dr. Bhagat received her doctorate degree in 2015 from Yale University and undergraduate degree from Franklin & Marshall College.
Postes actifs de Sarah Bhagat
| Sociétés | Poste | Début |
|---|---|---|
Aeovian Pharmaceuticals, Inc.
 Aeovian Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Directeur/Membre du Conseil | 01/09/2019 |
Anciens postes connus de Sarah Bhagat
| Sociétés | Poste | Fin |
|---|---|---|
| INOZYME PHARMA, INC. | Directeur/Membre du Conseil | 01/07/2025 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Analyste en capital-investissement | 01/08/2022 |
Atsena Therapeutics, Inc.
 Atsena Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage gene therapy company that develops treatments for inherited retinal diseases that cause blindness | Président | - |
Formation de Sarah Bhagat
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
92
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Franklin & Marshall College
 Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inozyme Pharma, Inc.
 Inozyme Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Health Technology |
Aeovian Pharmaceuticals, Inc.
Aeovian Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
Atsena Therapeutics, Inc.
Atsena Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage gene therapy company that develops treatments for inherited retinal diseases that cause blindness | Health Technology |
